Public market insider buying at Eastwood Bio-Medical Ca (EBM)

Public market insider buying at Eastwood Bio-Medical Ca (V:EBM)

Youngsoo Kim, CEO and 10% Holder, acquired 54,600 Common Shares on a direct ownership basis at a price of $2.700 on May 3rd, 2021. This represents a $147,420 investment into the company's shares and an account share holdings change of greater than 100%.

Eastwood Bio-Medical Ca is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Eastwood Bio-Medical Canada Inc. (EMBC) is a natural health supplement distribution company. The Company is engaged in the marketing and distributing natural health products in North America. It is a distributor of the Eleotin line of products, which include formulations based on natural ingredients. The Eleotin products include natural remedies for certain metabolic disorders, such as blood glucose disorders, hypertension and obesity. The Company's licensed products include Eleotin A 700, which is a treatment for spleen deficiency, lack of appetite and fatigue; Eleotin AL88, a laxative; Eleotin Cal20, for bone and teeth maintenance; Eleotin V3D for the development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55, a sedative and tension relief, Eleotin Zn330, which is involved in tissue formation and metabolism; Eleotin Bentley, which is used to promote healthy glucose levels, and Eleotin LBM, which is recommended for hypertension relief.